Streptokinase (Heber Biotec)

N/A

Report date: 2022/04/20 09:23:50

Base Information

Drug NameStreptokinase (Heber Biotec)
Drug Alias NamerSK suppository溶栓酶 - Heber Biotec链激酶 - Heber Biotecstreptokinasum重组链激酶直肠栓剂 +[8] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsIschemic StrokePancreatitisHemorrhoids
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesCenter For Genetic Engineering And Biotechnology
Inactive CompaniesUniversity Of AlbertaPostgraduate Institute Of Medical Education And Research
Active IndicationsHemorrhoids
Inactive IndicationsIschemic StrokePancreatitis

Other Information

ATC CodeB01AD01
Related LinksN/A